The discovery that certain high-risk strains of human papillomavirus (HR-HPV) cause nearly
100% of invasive cervical cancer has spurred a revolution in cervical cancer prevention by …

For the purpose of clinical trials, head and neck cancers have largely been considered as a
single disease entity. With the exception of nasopharyngeal cancers, important clinical …

Large-scale epidemiologic studies have been invaluable for elaboration of the causal
relationship between persistent detection of genital human papillomavirus (HPV) infection …

Determinants of genital human papillomavirus (HPV) persistence in 393 women initially
cytologically normal were investigated by testing them for HPV DNA twice over a median …

Background Male circumcision significantly reduced the incidence of human
immunodeficiency virus (HIV) infection among men in three clinical trials. We assessed the …

The prevalence and risk factors for oral human papillomavirus (HPV) infection are unknown,
despite evidence for an etiological role for HPV in oral cancers. Oral samples from human …

Objective The vaginal microbiota helps protect the female genital tract from disease. We
sought to describe the composition of the vaginal microbiota in premenopausal …

Background. We sought to describe the temporal relationship between vaginal microbiota
and human papillomavirus (HPV) detection. Methods. Thirty-two reproductive-age women …

Carcinogenic human papillomaviruses (HPV) are thought to be necessary for development
of cervical cancer. We assessed whether higher viral loads of such viruses predicted future …

Abstract Human papillomavirus (HPV)—16 causes about half the cases of cervical cancer
worldwide and is the focus of HPV vaccine development efforts. Systematic data are lacking …